CAMBRIDGE, Mass., Feb. 19, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ:BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced its participation in fireside chats at the following upcoming investor conferences:

NEW YORK, Feb. 19, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a pioneer in the global digital therapeutics market, today presented a new clinical study at the Advanced Technologies & Treatments for Diabetes ("ATTD") conference in

MISGAV, Israel and SINGAPORE, Feb. 19, 2020 /PRNewswire/ -- The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), is pleased to announce that its newly-formed fund, Trendlines Agrifood Fund Pte. Ltd. ("the Fund"), has made its first investment, inv

SAN DIEGO, Feb. 19, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the developmen

BOSTON, Feb. 19, 2020 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts (BCBSMA) today named six substance use treatment and recovery centers in

PLANO, Texas, Feb. 19, 2020 /PRNewswire/ -- VitalTech, a market leader in connected care, digital health and remote patient monitoring, announced today that it will be expanding the breadth of its existing services with the acquisition of Breezie™, a multitiered tablet-based platform that drives senior engagement and compliance.

INDIANAPOLIS, Feb. 19, 2020 /PRNewswire/ -- LifeOmic, the creator of the LIFE mobile apps and the Precision Health Cloud (PHC) platform in use at major medical and cancer centers, today announced

TAMPA, Fla., Feb. 19, 2020 /PRNewswire/ -- Dedicated to the physician leadership and management needs of physicians and non-clinical administrators, the American Association for Physician Leadership (www.phys

NORTH CHICAGO, Ill., Feb. 19, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Cowen 40th Annual Health Care Conference on Wednesday, March 4, 2020.  Michael Severino, M.D., vice chairman and president and

Enables in-house product development and testing, eliminating dependency on third parties Allows TGOD to perform sensory testing for new and existing products, including for premium quality attributes Adds another layer of rigour and quality control, ensuring product consistency TORONTO, Feb. 19, 2020